#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA664612	Functional	Ability to inhibit growth of Dictostelium discoideum.	Dictyostelium discoideum	16	ALA1135492	organism-based format	Scientific Literature
2.	ALA676676	Functional	In vitro growth inhibition against Entamoeba histolytica	Entamoeba histolytica	102	ALA1148279	organism-based format	Scientific Literature
3.	ALA681824	Functional	Inhibitory activity, for stimulation of TNF-alpha release in gamma-delta T cells, using a constrained maximum TNF-alpha release of 2700 pg/mL	Homo sapiens	61	ALA1148380	cell-based format	Scientific Literature
4.	ALA681825	Functional	Inhibitory activity, for stimulation of TNF-alpha release in gamma-delta T cells, using individual observed maximum TNF-alpha release	Homo sapiens	45	ALA1148380	cell-based format	Scientific Literature
5.	ALA681826	Functional	pIC50 value for stimulation of TNF-alpha release in gamma-delta T cells, using a constrained maximum TNF-alpha release of 2700 pg/mL	Homo sapiens	61	ALA1148380	cell-based format	Scientific Literature
6.	ALA681827	Functional	pIC50 value for stimulation of TNF-alpha release in gamma-delta T cells, using individual observed maximum TNF-alpha release	Homo sapiens	45	ALA1148380	cell-based format	Scientific Literature
7.	ALA681890	Binding	Inhibitory activity against farnesyl Pyrophosphate Synthase was determined	Leishmania major	61	ALA1145906	single protein format	Scientific Literature
8.	ALA681891	Binding	Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand	Leishmania major	62	ALA1145906	single protein format	Scientific Literature
9.	ALA857167	Binding	Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M)	Leishmania major	61	ALA1145906	single protein format	Scientific Literature
10.	ALA700364	Toxicity	Toxicity evaluated against human nasopharyngeal carcinoma KB cell line	Homo sapiens	102	ALA1148279	cell-based format	Scientific Literature
11.	ALA835402	ADME	Therapeutic index (TI) value as ratio of lethal dose (LD50) to the inhibitory concentration (IC50)		41	ALA1143625	cell-based format	Scientific Literature
12.	ALA874944	Functional	In vitro inhibitory concentration against the growth of Toxoplasma gondii in human foreskin fibroblast monolayer cells (HFF cells)		60	ALA1143625	cell-based format	Scientific Literature
13.	ALA836410	Functional	Lethal dose required to inhibit the growth of human KB (nasopharyngeal carcinoma) cell line	Homo sapiens	41	ALA1143625	cell-based format	Scientific Literature
14.	ALA910461	Functional	Antibacterial activity against Escherichia coli W3110	Escherichia coli	117	ALA1138862	organism-based format	Scientific Literature
15.	ALA910462	Functional	Antibacterial activity against Escherichia coli pTMV19	Escherichia coli	47	ALA1138862	organism-based format	Scientific Literature
16.	ALA910463	Functional	Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate	Escherichia coli	47	ALA1138862	organism-based format	Scientific Literature
17.	ALA1217000	Functional	Antimicrobial activity against Plasmodium falciparum	Plasmodium falciparum	630	ALA1212812	organism-based format	Scientific Literature
18.	ALA1217007	Functional	Antimicrobial activity against Entamoeba histolytica	Entamoeba histolytica	304	ALA1212812	organism-based format	Scientific Literature
19.	ALA769481	Functional	In vitro growth inhibition against Plasmodium falciparum	Plasmodium falciparum	102	ALA1148279	organism-based format	Scientific Literature
20.	ALA786021	Functional	Bone resorption activity in rats.	Rattus norvegicus	35	ALA1135492	organism-based format	Scientific Literature